Shankar G, Bryson J S, Jennings C D, Morris P E, Cohen D A
Department of Microbiology, University of Kentucky Chandler Medical Center, Lexington 40536-0084, USA.
Am J Respir Cell Mol Biol. 1998 Feb;18(2):235-42. doi: 10.1165/ajrcmb.18.2.2988.
Pulmonary complications are a major clinical problem following allogeneic bone marrow transplantation (BMT), contributing to more than 30% of transplant-related mortalities. Idiopathic pneumonia syndrome is responsible for significant mortality among BMT patients. However, the etiology of injury to the lung parenchyma by this disease syndrome is unknown and it has been difficult to evaluate the cellular and molecular mechanisms underlying IPS in the absence of a suitable animal model. To study post-BMT lung disease during graft-versus-host disease (GVHD), we have developed a murine model that utilizes a semi-allogeneic parental --> F1 transplant strategy to induce a mild form of GVHD. Progressive inflammatory lung disease developed in animals with mild GVHD, as indicated by changes in immune cell distribution and cytokine expression in the lungs of transplanted animals. Histologic analysis of lung tissue from GVHD mice at 3 wk post-BMT showed minor immunopathologic changes compared with control mice. In contrast, lungs of GVHD mice at 12 wk displayed histopathologic hallmarks of interstitial pneumonitis, such as prominent perilumenal mononuclear cell infiltration and areas of alveolar congestion. Flow cytometric analysis of lung interstitial cells of GVHD mice revealed an increase in CD8+ T-cells at week 3, which decreased to normal levels by week 12 post-BMT. Simultaneously, the percentage of CD4+ T-cells increased progressively above normal levels and peaked at week 7 post-BMT. Analysis of cytokine mRNA expression in lung tissue indicated that steady state levels of interleukin (IL)-1beta, tumor necrosis factor (TNF)-alpha, interferon-gamma, and IL-12 were significantly elevated in lungs of GVHD mice at 3 wk post-BMT compared with untreated controls. Mice that were transplanted with allogeneic bone marrow alone (BMT controls) also displayed elevated expression of these cytokines, although only IL-6 was significantly higher than in untreated controls. In contrast, at 12 wk after transplantation only TNF-alpha and IL-12 levels remained elevated in GVHD mice, suggesting prolonged macrophage activation. On the basis of these findings, we conclude that allogeneic bone marrow transplantation in this mouse model causes a progressive interstitial pneumonitis, which is characterized by an acute influx of CD8+ T-cells, followed in the chronic phase by a prominent accumulation of CD4+ T-cells, and is associated with persistent production of cytokines known to activate macrophages.
肺部并发症是异基因骨髓移植(BMT)后的一个主要临床问题,在超过30%的移植相关死亡病例中起作用。特发性肺炎综合征是BMT患者中导致显著死亡率的原因。然而,这种疾病综合征对肺实质造成损伤的病因尚不清楚,并且在缺乏合适动物模型的情况下,很难评估特发性肺炎综合征(IPS)潜在的细胞和分子机制。为了研究移植物抗宿主病(GVHD)期间BMT后的肺部疾病,我们开发了一种小鼠模型,该模型采用半同种异体亲代→F1移植策略来诱导轻度GVHD。如移植动物肺部免疫细胞分布和细胞因子表达的变化所示,轻度GVHD的动物出现了进行性炎症性肺病。BMT后3周对GVHD小鼠肺组织进行组织学分析,结果显示与对照小鼠相比,免疫病理变化较小。相反,GVHD小鼠在12周时的肺脏显示出间质性肺炎的组织病理学特征,如显著的管周单核细胞浸润和肺泡充血区域。对GVHD小鼠肺间质细胞进行流式细胞术分析发现,在第3周时CD8 + T细胞增加,在BMT后第12周时降至正常水平。同时,CD4 + T细胞的百分比逐渐增加至高于正常水平,并在BMT后第7周达到峰值。对肺组织中细胞因子mRNA表达的分析表明,与未处理的对照相比,BMT后3周时GVHD小鼠肺中白细胞介素(IL)-1β、肿瘤坏死因子(TNF)-α、干扰素-γ和IL-12的稳态水平显著升高。仅接受同种异体骨髓移植的小鼠(BMT对照)也显示出这些细胞因子的表达升高,尽管只有IL-6显著高于未处理的对照。相反,在移植后12周时GVHD小鼠中仅TNF-α和IL-12水平仍然升高,提示巨噬细胞的持续激活。基于这些发现,我们得出结论,在该小鼠模型中,同种异体骨髓移植导致进行性间质性肺炎,其特征是CD8 + T细胞急性流入,在慢性期则是CD4 + T细胞显著积聚,并且与已知可激活巨噬细胞的细胞因子持续产生有关。